GB201915598D0 - Methods for determining the invasive and/or metastic potential of a tumour - Google Patents

Methods for determining the invasive and/or metastic potential of a tumour

Info

Publication number
GB201915598D0
GB201915598D0 GB201915598A GB201915598A GB201915598D0 GB 201915598 D0 GB201915598 D0 GB 201915598D0 GB 201915598 A GB201915598 A GB 201915598A GB 201915598 A GB201915598 A GB 201915598A GB 201915598 D0 GB201915598 D0 GB 201915598D0
Authority
GB
United Kingdom
Prior art keywords
tumour
invasive
determining
methods
metastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201915598A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bradford
Original Assignee
University of Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bradford filed Critical University of Bradford
Priority to GB201915598A priority Critical patent/GB201915598D0/en
Publication of GB201915598D0 publication Critical patent/GB201915598D0/en
Priority to US17/755,279 priority patent/US20220404365A1/en
Priority to PCT/GB2020/052718 priority patent/WO2021084242A1/en
Priority to CN202080076313.9A priority patent/CN114641582A/en
Priority to EP20800285.7A priority patent/EP4052039A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB201915598A 2019-10-28 2019-10-28 Methods for determining the invasive and/or metastic potential of a tumour Ceased GB201915598D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB201915598A GB201915598D0 (en) 2019-10-28 2019-10-28 Methods for determining the invasive and/or metastic potential of a tumour
US17/755,279 US20220404365A1 (en) 2019-10-28 2020-10-27 Methods for determining the invasive and/or metastatic potential of a tumour
PCT/GB2020/052718 WO2021084242A1 (en) 2019-10-28 2020-10-27 Methods for determining the invasive and/or metastatic potential of a tumour
CN202080076313.9A CN114641582A (en) 2019-10-28 2020-10-27 Method for determining the invasiveness and/or the metastatic potential of a tumor
EP20800285.7A EP4052039A1 (en) 2019-10-28 2020-10-27 Methods for determining the invasive and/or metastatic potential of a tumour

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201915598A GB201915598D0 (en) 2019-10-28 2019-10-28 Methods for determining the invasive and/or metastic potential of a tumour

Publications (1)

Publication Number Publication Date
GB201915598D0 true GB201915598D0 (en) 2019-12-11

Family

ID=68768868

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201915598A Ceased GB201915598D0 (en) 2019-10-28 2019-10-28 Methods for determining the invasive and/or metastic potential of a tumour

Country Status (5)

Country Link
US (1) US20220404365A1 (en)
EP (1) EP4052039A1 (en)
CN (1) CN114641582A (en)
GB (1) GB201915598D0 (en)
WO (1) WO2021084242A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113502328A (en) * 2021-05-27 2021-10-15 深圳市人民医院 Application of reagent for detecting expression level of marker in sample in preparation of kit for detecting or diagnosing breast cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1110799A (en) * 1997-10-29 1999-05-17 Warner-Lambert Company Method of inhibiting metastases of cancer cells
WO2008035096A1 (en) * 2006-09-20 2008-03-27 Queen's University Of Belfast Assay
US11913957B2 (en) * 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
WO2018065771A1 (en) * 2016-10-05 2018-04-12 University Of Bradford Inhibitor of ran at transcriptional level for use in the treatment of cancer
GB2554703A (en) * 2016-10-05 2018-04-11 Univ Bradford Compound for use in medicine

Also Published As

Publication number Publication date
US20220404365A1 (en) 2022-12-22
CN114641582A (en) 2022-06-17
EP4052039A1 (en) 2022-09-07
WO2021084242A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
GB201814620D0 (en) Analysis of cardiac data
EP3580622C0 (en) General planning of production- and / or maintenanceplans
EP3580560A4 (en) Methods for the detection and treatment of lung cancer
EP3704268A4 (en) Normalizing tumor mutation burden
IL268815A (en) Compositions and methods for tumor transduction
EP3292511A4 (en) Computer-assisted tumor response assessment and evaluation of the vascular tumor burden
EP3615025A4 (en) Nrf and hif activators/hdac inhibitors and therapeutic methods using the same
SG11202000838SA (en) Moisture tight containers and methods of making and using the same
IL261047A (en) Taf1 inhibitors for the therapy of cancer
IL273782A (en) Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same
EP3863615A4 (en) Methods for the treatment of solid tumor cancers using illudins and biomarkers
IL270717A (en) Biomarkers for diagnosis of lung cancer
SG11202001432WA (en) Improving the taste of consumables
GB2569154B (en) Methods and systems for determining the shape of a radiotherapy beam
IL272810A (en) Methods of diagnosing and treating lung cancer
GB201814350D0 (en) Diagnosis of cancer
GB201915598D0 (en) Methods for determining the invasive and/or metastic potential of a tumour
EP3607066A4 (en) Methods of detecting lung cancer
EP3607320A4 (en) Compositions and methods of diagnosing pancreatic cancer
GB201619808D0 (en) Biomarkers for the prognosis and diagnosis of cancer
GB201911216D0 (en) Methods of determining the margin of a tumour
FI3918377T3 (en) Improved metal-detector means for locating the presence of metallic objects
GB201905861D0 (en) Methods of detecting cancer
EP3716973A4 (en) Methods of inhibiting tumor metastasis
LT3794148T (en) Methods for the diagnosis of aneurysm or cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)